-
Azilsartan in Reliable Cell Assays
2026-09-21
This scenario-based guide explains how Azilsartan (TAK-536, SKU B2210) can improve interpretation of viability, proliferation, and inflammation assays by providing selective AT1 receptor pharmacology. It covers solvent compatibility, concentration planning, controls, data interpretation, and practical supplier-selection criteria.
-
D-N-Acetylgalactosamine Protocol Guide
2026-09-21
D-N-Acetylgalactosamine provides a defined, water-soluble reagent for glycoprotein constituent measurements and brain heteropolysaccharides analysis. It is appropriate for freshly prepared aqueous or compatible DMSO workflows, but not for ethanol-based protocols or long-term storage of prepared solutions.
-
Cell Counting Kit-8 (CCK-8) Plus: Practical Guide
2026-09-20
Cell Counting Kit-8 Plus (SKU K2268) provides a water-soluble WST-8 readout for estimating viable-cell signal in proliferation, cytotoxicity, and drug-response experiments. It is appropriate as a controlled metabolic endpoint, but should not be treated as a direct cell count or stand-alone proof of a death mechanism, compound selectivity, or target-specific drug action.
-
Chenodeoxycholic Acid: Mechanism Beyond FXR
2026-09-19
Chenodeoxycholic Acid (CDCA) is more than a bile acid ligand: it can serve as a mechanistic probe linking FXR activation to transcriptional and inflammatory outcomes. This article explains how to design interpretation-focused experiments using CDCA, including insights from the FXR–KLF11 pathway in contrast-induced acute kidney injury.
-
Hierarchical Mitochondrial Repair in Diabetic Periodontitis
2026-09-18
The reference study develops a macrophage-targeted, ROS-responsive nanoparticle–hydrogel platform that delivers MitoQ to dysfunctional mitochondria in M1 macrophages. By combining selective cellular uptake, mitochondrial repair, ROS-triggered release, and local periodontal retention, the system reduced inflammatory signaling and improved alveolar bone regeneration in a diabetic periodontitis model.
-
ATM Inhibition Drives Metabolic Adaptation
2026-09-18
Huang et al. show that suppressing ATM promotes macropinocytosis, allowing cancer cells to acquire extracellular nutrients and survive under nutrient-poor conditions. The study identifies branched-chain amino acid dependence as a metabolic vulnerability created by ATM inhibition and supports combined targeting of ATM signaling and macropinocytosis.
-
TUNEL Assay: From DNA Damage to Translation
2026-09-17
A translational framework for using TUNEL-based DNA fragmentation analysis to connect apoptosis biology with vascular repair, blood-spinal cord barrier integrity, and therapeutic decision-making after spinal cord injury.
-
Lysosomal β-Galactosidase Staining Kit for Senescence
2026-09-17
Use X-gal chromogenic staining to visualize lysosomal acidic β-galactosidase in cultured cells and tissue sections while keeping senescence interpretation appropriately controlled. This guide connects practical cell senescence staining with cisplatin-resistance research, emphasizing workflow reproducibility, consumable compatibility, and the limits of β-galactosidase as a standalone biomarker.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-09-16
This guide explains how to use the Anti-HMGB1 Rabbit Monoclonal Antibody, SKU MA3057, for practical HMGB1 detection in Western blot, immunohistochemistry, and flow cytometry workflows. It is a research-use reagent supported by product dossier information, not a diagnostic, therapeutic, or clinically validated assay component, and no directly matched paper evidence is assumed.
-
Machine Learning for Senolytic Discovery
2026-09-16
The reference study shows that cost-effective machine-learning models trained on published screening data can identify senolytic candidates despite small and heterogeneous datasets. Computational screening followed by human-cell validation identified ginkgetin, periplocin, and oleandrin, demonstrating a practical route to reduce early-stage discovery costs while preserving experimental selectivity testing.
-
Azilsartan: Designing Causal RAS–SIRT3 Assays
2026-09-15
Azilsartan and TAK-536 provide a precise pharmacological probe for AT1-dependent signaling. This article translates astrocyte–microglia findings into practical assay-design decisions, emphasizing controls, readout interpretation, and translational limits.
-
Amorolfine Hydrochloride for Yeast Membrane Studies
2026-09-15
Use Amorolfine Hydrochloride as a controlled membrane-synthesis perturbation alongside ploidy, cell size, DNA content, and ergosterol-linked transcriptional readouts. This workflow distinguishes fungal cell membrane disruption from generic growth inhibition and supports mechanism, fungal infection research, and antifungal resistance studies.
-
BHBA: From Ketosis to Stroke Neuroprotection
2026-09-14
3-hydroxybutyrate (BHBA) is both a fatty acid β-oxidation metabolite and a ketone body signaling molecule. This article translates evidence linking BHBA to ferroptosis control in ischemic stroke into a practical framework for mechanistic validation, epigenetic studies, and translational assay design.
-
Perospirone: Receptor and Kv1.5 Research Workflow
2026-09-14
Perospirone (SM-9018 free base) enables paired investigation of serotonergic and dopaminergic signaling pathways and vascular Kv-channel pharmacology. This workflow separates nanomolar receptor activity from micromolar Kv1.5-related inhibition, helping researchers build more informative schizophrenia research and cardiovascular assays.
-
Ampicillin Sodium: Assay and Workflow Guide
2026-09-13
Ampicillin sodium supports two complementary research needs: controlled selection during recombinant protein production and mechanism-focused antibacterial activity assays. This guide connects a classic annexin V purification workflow with practical assay design, stability controls, resistance-aware interpretation, and troubleshooting strategies.